Addex Therapeutics Ltd (ADXN)
9.44
+0.49
(+5.47%)
USD |
NASDAQ |
May 10, 16:00
9.44
0.00 (0.00%)
After-Hours: 19:30
Addex Therapeutics Total Assets (Quarterly): 5.526M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.526M |
| September 30, 2023 | 6.709M |
| June 30, 2023 | 10.01M |
| March 31, 2023 | 7.985M |
| December 31, 2022 | 8.933M |
| September 30, 2022 | 12.55M |
| June 30, 2022 | 11.93M |
| March 31, 2022 | 19.15M |
| December 31, 2021 | 24.66M |
| September 30, 2021 | 19.33M |
| June 30, 2021 | 23.38M |
| March 31, 2021 | 28.53M |
| December 31, 2020 | 23.10M |
| September 30, 2020 | 21.36M |
| June 30, 2020 | 24.34M |
| March 31, 2020 | 30.08M |
| December 31, 2019 | 34.09M |
| June 30, 2019 | 38.87M |
| December 31, 2018 | 42.88M |
| June 30, 2018 | 44.97M |
| June 30, 2018 | 44.97M |
| December 31, 2017 | 3.145M |
| Date | Value |
|---|---|
| June 30, 2017 | 4.026M |
| June 30, 2017 | 4.026M |
| December 31, 2016 | 1.654M |
| June 30, 2016 | 2.655M |
| June 30, 2016 | 2.655M |
| December 31, 2015 | 2.924M |
| June 30, 2015 | 4.210M |
| June 30, 2015 | 4.210M |
| December 31, 2014 | 4.044M |
| June 30, 2014 | 4.949M |
| June 30, 2014 | 4.949M |
| December 31, 2013 | 6.625M |
| June 30, 2013 | 9.997M |
| June 30, 2013 | 9.997M |
| December 31, 2012 | 23.81M |
| June 30, 2012 | 29.15M |
| June 30, 2012 | 29.15M |
| December 31, 2011 | 46.37M |
| June 30, 2011 | 71.45M |
| December 31, 2010 | 79.47M |
| June 30, 2010 | 63.22M |
| December 31, 2009 | 85.51M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
5.526M
Minimum
Dec 2023
38.87M
Maximum
Jun 2019
19.47M
Average
20.35M
Median
Total Assets (Quarterly) Benchmarks
| AC Immune SA | 217.65M |
| CRISPR Therapeutics AG | 2.230B |
| NLS Pharmaceutics Ltd | 2.270M |
| Molecular Partners AG | 236.15M |
| MoonLake Immunotherapeutics | 564.12M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.163M |
| Shareholders Equity (Quarterly) | 1.364M |
| Current Ratio | 1.464 |